Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
TB Alliance
TB Alliance
Activities:
Research & Development
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Drug Delivery
World's first child-friendly TB medicines in correct doses
The new fixed-dose formulations for children will offer hope for the 400 children who needlessly die of TB each day
Research & Development
Novartis supplies tuberculosis drug candidates to TB Alliance
Included are drugs called indolcarboxamides that are active against drug sensitive and multi-resistant strains of TB
Research & Development
Sanofi and TB Alliance to accelerate TB drug development
Research collaboration will focus on optimising and developing compounds in the Sanofi library
Research & Development
South African trial milestone signals TB drug breakthrough
Combination of three drugs able to kill TB bacteria within two weeks
Research & Development
China to establish international r&d centre for global health
Partnership joins public and private sectors to develop new treatments for TB, malaria and HIV/AIDS
Research & Development
TB Alliance and AstraZeneca to fight tuberculosis
Agree to new research to speed up development of TB drugs
Subscribe now